Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps - Contacts and Locations

Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005882

Locations


United States, Arizona
	Arizona Cancer Center
	Tucson, Arizona, United States, 85724-5024

United States, California
	Chao Family Comprehensive Cancer Center
	Orange, California, United States, 92868
	Veterans Affairs Medical Center - Loma Linda (Pettis)
	Loma Linda, California, United States, 92357

United States, Colorado
	University of Colorado Cancer Center
	Denver, Colorado, United States, 80010

Sponsors and Collaborators

Chao Family Comprehensive Cancer Center

National Cancer Institute (NCI)

Investigators


Study Chair:	Frank L. Meyskens, MD, FACP	Chao Family Comprehensive Cancer Center